Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 44Lung Neoplasms 29Neuroblastoma 24Small Cell Lung Carcinoma 21Carcinoma, Ovarian Epithelial 19Fallopian Tube Neoplasms 17Neoplasms 14Brain Neoplasms 14Uterine Cervical Neoplasms 11Leukemia, Myeloid, Acute 11Leukemia 11Retinoblastoma 10Glioma 9Recurrence 8Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Central Nervous System Neoplasms 7Sarcoma, Ewing 6Neoplasm Metastasis 6Lymphoma, Follicular 6Unspecified Adult Solid Tumor, Protocol Specific 5Osteosarcoma 5Gliosarcoma 5Glioblastoma 5Endometrial Neoplasms 5Burkitt Lymphoma 5Blast Crisis 5Astrocytoma 5Wilms Tumor 4

Interventions

Cisplatin 7Etoposide 6Amifostine 6Radiotherapy 5Drug Therapy 5Cyclophosphamide 5apatinib 4Methotrexate 4Filgrastim 4Cytarabine 4sodium thiosulfate 3Methylprednisolone 3Carboplatin 3pegfilgrastim 2glucarpidase 2etoposide phosphate 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Nivolumab 2Gemcitabine 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Capecitabine 2trastuzumab deruxtecan 1selinexor 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × Topotecan × Clear all
NCT00006012 2016-07-06

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 1/2 Completed
73 enrolled
Thoracic

Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡